Compensation refers to correcting a phenomenon called fluorescence spillover in flow cytometric analysis. This is the removal of the signal of any given fluorochrome from all detectors except the one ...
In recent years, flow cytometric immunophenotyping has evolved from indirect immunofluorescence techniques to a complex multiparametric diagnostic tool, which is indispensable for the diagnosis of ...
A recent study described the use of multiparameter flow cytometry to detect minimal residual disease, with an 8-color flow cytometric method with a 105 sensitivity, using monoclonal antibodies in ...
Beckman Coulter Life Sciences has introduced the DxFLEX, Europe’s first CE-IVD, 13-color clinical flow cytometry system. The sensitivity and resolution of the DxFLEX expands laboratory testing ...
[Fremont, CA, USA] – Flow cytometry’s next chapter is here. Opening the door to deeper immunological insights, Cytek Biosciences Inc., a leading provider of flow cytometry instrumentation, announced ...
A decade after introducing the NovoCyte flow cytometry platform, Agilent Technologies has unveiled the latest addition to its portfolio, the NovoCyte Opteon Spectral Flow Cytometer. Capable of ...
Clinical flow cytometry applications are performed with validated protocols, which have been carefully designed to consider the optimal fluorophore combinations to minimize spectral overlap and for ...
SAN DIEGO — Today Invivoscribe, a global leader in precision diagnostics, announced the launch of a new 12-color multiparametric flow cytometry service in Shanghai, China, the newest reference ...
The Flow Cytometry shared resource stays at the leading edge of technology. Close ties to industry allow us to offer users early access to new reagents and instrumentation. We help users realize a ...
Flow cytometry is a way to look closely at the features of cells or particles. A sample of blood or tissue goes into a machine called a cytometer. In less than a minute, a computer can analyze ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results